✦ LIBER ✦

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

✍ Scribed by Suzuki, Yasuo; Motoya, Satoshi; Hanai, Hiroyuki; Matsumoto, Takayuki; Hibi, Toshifumi; Robinson, Anne M.; Mostafa, Nael M.; Chao, Jingdong; Arora, Vipin; Camez, Anne; Thakkar, Roopal B.; Watanabe, Mamoru

Book ID: 121551430
Publisher: Springer Japan
Year: 2013
Tongue: English
Weight: 345 KB
Volume: 49
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-013-0922-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1204 Pharmacokinetics of Adalimumab in

Sa1204 Pharmacokinetics of Adalimumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

✍ Awni, Walid M.; Eckert, Doerthe; Sharma, Shringi; Mostafa, Nael M.; Noertersheus 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 170 KB

P412 Pharmacokinetics of adalimumab in a

P412 Pharmacokinetics of adalimumab in adult patients with moderately to severely active ulcerative colitis

✍ Awni, W.; Eckert, D.; Sharma, S.; Mostafa, N.; Noertersheuser, P.; Pradhan, R.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 56 KB

Escalation to weekly dosing recaptures r

Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis

✍ Wolf, D.; D'Haens, G.; Sandborn, W. J.; Colombel, J.-F.; Van Assche, G.; Robinso 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB

847t Adalimumab for Induction of Clinica

847t Adalimumab for Induction of Clinical Remission in Moderately to Severely Active Ulcerative Colitis

✍ Walter Reinisch; William J. Sandborn; Daniel W. Hommes; Geert R. D'Haens; Stephe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 185 KB

P519 Efficacy of Adalimumab in children

P519 Efficacy of Adalimumab in children and adolescents with moderate/ severe ulcerative colitis

✍ Volonaki, E.; Martins, M.; Cococcioni, L.; Malamisura, M.; Shah, N.; Lindley, K. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 49 KB

Long-term safety and efficacy of adalimu

Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease

✍ Watanabe, Mamoru; Hibi, Toshifumi; Mostafa, Nael M.; Chao, Jingdong; Arora, Vipi 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 945 KB